Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Baker, AH' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 48 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nicklin, SA; Von Seggern, DJ; Work, LM; Pek, DCK; Dominiczak, AF; Nemerow, GR; Baker, AH
      Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus

      MOLECULAR THERAPY
    2. Nicklin, SA; Buening, H; Dishart, KL; de Alwis, M; Girod, A; Hacker, U; Thrasher, AJ; Ali, RR; Hallek, M; Baker, AH
      Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

      MOLECULAR THERAPY
    3. Reynolds, PN; Nicklin, SA; Kaliberova, L; Boatman, BG; Grizzle, WE; Balyasnikova, IV; Baker, AH; Danilov, SM; Curiel, DT
      Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo

      NATURE BIOTECHNOLOGY
    4. Hu, YH; Baker, AH; Zou, YP; Newby, AC; Xu, QB
      Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    5. George, SJ; Angelini, GD; Capogrossi, MC; Baker, AH
      Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosis

      GENE THERAPY
    6. Nicklin, SA; Reynolds, PN; Brosnan, MJ; White, SJ; Curiel, DT; Dominiczak, AF; Baker, AH
      Analysis of cell-specific promoters for viral gene therapy targeted at thevascular endothelium

      HYPERTENSION
    7. White, SJ; Nicklin, SA; Sawamura, T; Baker, AH
      Identification of peptides that target the endothelial cell-specific LOX-1receptor

      HYPERTENSION
    8. Bond, M; Chase, AJ; Baker, AH; Newby, AC
      Inhibition of transcription factor NF-kappa B reduces matrix metalloproteinase-1,-3 and-9 production by vascular smooth muscle cells

      CARDIOVASCULAR RESEARCH
    9. Apparailly, F; Noel, D; Millet, V; Baker, AH; Lisignoli, G; Jacquet, C; Kaiser, MJ; Sany, J; Jorgensen, C
      Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritis

      ARTHRITIS AND RHEUMATISM
    10. George, SJ; Baker, AH
      Gene transfer to the vasculature - Historical perspective and implicationsfor future research objectives

      ATHEROSCLEROSIS : EXPERIMENTAL METHODS AND PROTOCOLS
    11. Lloyd, CT; George, SJ; Angelini, GD; Newby, AC; Baker, AH
      A pig model of vein graft disease - Applications for potential gene therapies

      ATHEROSCLEROSIS : EXPERIMENTAL METHODS AND PROTOCOLS
    12. Ashworth, M; Baker, AH
      'Time and space': carers' views about respite care

      HEALTH & SOCIAL CARE IN THE COMMUNITY
    13. Baker, AH; Ahonen, M; Kahari, VM
      Potential applications of tissue inhibitor of metalloproteinase (TIMP) overexpression for cancer gene therapy

      CANCER GENE THERAPY
    14. Bond, P; Murphy, G; Bennett, MR; Amour, A; Knauper, V; Newby, AC; Baker, AH
      Locatization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus - Metalloproteinase inhibition is associated with proapoptotic activity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    15. Vieillard-Baron, A; Frisdal, E; Eddahibi, S; Deprez, I; Baker, AH; Newby, AC; Berger, P; Levame, M; Raffestin, B; Adnot, S; d'Ortho, MP
      Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer or doxycycline aggravates pulmonary hypertension in rats

      CIRCULATION RESEARCH
    16. Nicklin, SA; White, SJ; Watkins, SJ; Hawkins, RE; Baker, AH
      Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display

      CIRCULATION
    17. George, SJ; Lloyd, CT; Angelini, GD; Newby, AC; Baker, AH
      Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3

      CIRCULATION
    18. Brand, K; Baker, AH; Perez-Canto, A; Possling, A; Sacharjat, M; Geheeb, M; Arnold, W
      Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue

      CANCER RESEARCH
    19. Kranzhofer, A; Baker, AH; George, SJ; Newby, AC
      Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    20. Newby, AC; Baker, AH
      Targets for gene therapy of vein grafts

      CURRENT OPINION IN CARDIOLOGY
    21. Baker, AH; George, SJ; Zaltsman, AB; Murphy, G; Newby, AC
      Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3

      BRITISH JOURNAL OF CANCER
    22. Lei, HQ; Kalluri, R; Furth, EE; Baker, AH; Strauss, JF
      Rat amnion type IV collagen composition and metabolism: Implications for membrane breakdown

      BIOLOGY OF REPRODUCTION
    23. Bond, M; Baker, AH; Newby, AC
      Nuclear factor kappa B activity is essential for matrix metalloproteinase-1 and-3 upregulation in rabbit dermal fibroblasts

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    24. GEORGE SJ; JOHNSON JL; ANGELINI GD; NEWBY AC; BAKER AH
      ADENOVIRUS-MEDIATED GENE-TRANSFER OF THE HUMAN TIMP-1 GENE INHIBITS SMOOTH-MUSCLE CELL-MIGRATION AND NEOINTIMAL FORMATION IN HUMAN SAPHENOUS-VEIN

      Human gene therapy
    25. GEORGE SJ; BAKER AH; ANGELINI GD; NEWBY AC
      GENE-TRANSFER OF TISSUE INHIBITOR OF METALLOPROTEINASE-2 INHIBITS METALLOPROTEINASE ACTIVITY AND NEOINTIMA FORMATION IN HUMAN SAPHENOUS VEINS

      Gene therapy
    26. Baker, AH; Denning, AC; Kostin, I; Schwartz, L
      How accurate are women's estimates of date of onset of next menses?

      PSYCHOLOGY & HEALTH
    27. MCGLYNN H; BAKER AH; PADUA RA
      BIOLOGICAL CONSEQUENCES OF A POINT MUTATION AT CODON-969 OF THE FMS GENE

      Leukemia research
    28. AHONEN M; BAKER AH; KAHARI VM
      ADENOVIRUS-MEDIATED DELIVERY OF TISSUE INHIBITOR OF METALLOPROTEINASE-1, METALLOPROTEINASE-2, AND METALLOPROTEINASE-3 GENES INHIBITS INVASION OF METASTATIC MELANOMA-CELLS

      Journal of investigative dermatology
    29. BAKER AH; ZALTSMAN AB; GEORGE SJ; NEWBY AC
      DIVERGENT EFFECTS OF TISSUE INHIBITOR OF METALLOPROTEINASE-1, METALLOPROTEINASE-2, OR METALLOPROTEINASE-3 OVEREXPRESSION ON RAT VASCULAR SMOOTH-MUSCLE CELL INVASION, PROLIFERATION, AND DEATH IN-VITRO - TIMP-3 PROMOTES APOPTOSIS

      The Journal of clinical investigation
    30. BOND M; FABUNMI RP; BAKER AH; NEWBY AC
      SYNERGISTIC UP-REGULATION OF METALLOPROTEINASE-9 BY GROWTH-FACTORS AND INFLAMMATORY CYTOKINES - AN ABSOLUTE REQUIREMENT FOR TRANSCRIPTION FACTOR NF-KAPPA-B

      FEBS letters
    31. AHONEN M; BAKER AH; KAHARI VM
      ADENOVIRUS-MEDIATED GENE DELIVERY OF TISSUE INHIBITOR OF METALLOPROTEINASES-3 INHIBITS INVASION AND INDUCES APOPTOSIS IN MELANOMA-CELLS

      Cancer research
    32. MCELLIGOTT AM; BAKER AH; MCGLYNN H
      THE EFFECT OF ADENOVIRAL GENE-TRANSFER OF MMP AND TIMP ON A RENAL-CELL LINE

      British Journal of Cancer
    33. ARMSTRONG D; BAKER AH
      HEALTH-CARE PROVIDERS VIEWS ABOUT AN URBAN-COMMUNITY HOSPITAL

      Health & social care in the community
    34. AHONEN M; BAKER AH; KAHARI VM
      HIGH-LEVEL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1, METALLOPROTEINASE-2, AND METALLOPROTEINASE-3 IN MELANOMA-CELLS ACHIEVED BY ADENOVIRUS-MEDIATED GENE DELIVERY

      Cancer gene therapy
    35. MCELLIGOTT AM; BAKER AH; MCGLYNN H
      TISSUE INHIBITOR OF METALLOPROTEINASE GENE-EXPRESSION - A TARGET FOR GENE-THERAPY IN RENAL-CELL CARCINOMA

      Cancer gene therapy
    36. AHONEN M; BAKER AH; KAHARI VM
      HIGH-LEVEL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1, METALLOPROTEINASE-2, AND METALLOPROTEINASE-3 IN MELANOMA-CELLS ACHIEVED BY ADENOVIRUS-MEDIATED GENE-TRANSFER

      Journal of investigative dermatology
    37. BAKER AH; MEHTA D; GEORGE SJ; ANGELINI GD
      PREVENTION OF VEIN GRAFT FAILURE - POTENTIAL APPLICATIONS FOR GENE-THERAPY

      Cardiovascular Research
    38. KRANZHOFER A; BAKER AH; NEWBY AC
      EXPRESSION OF TISSUE INHIBITORS OF METALLOPROTEINASES (TIMPS) IN HUMAN SAPHENOUS-VEIN

      HEART
    39. BAKER AH; WILKINSON GWG; HEMBRY RM; MURPHY G; NEWBY AC
      DEVELOPMENT OF RECOMBINANT ADENOVIRUSES THAT DRIVE HIGH-LEVEL EXPRESSION OF THE HUMAN METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 AND METALLOPROTEINASE-2 GENES - CHARACTERIZATION OF THEIR INFECTION INTO RABBIT SMOOTH-MUSCLE CELLS AND HUMAN MCF-7 ADENOCARCINOMA CELLS

      Matrix biology
    40. FABUNMI RP; BAKER AH; MURRAY EJ; BOOTH RFG; NEWBY AC
      DIVERGENT REGULATION BY GROWTH-FACTORS AND CYTOKINES OF 95-KDA AND 72-KDA GELATINASES AND TISSUE INHIBITORS OF METALLOPROTEINASE-1, METALLOPROTEINASE-2 AND METALLOPROTEINASE-3 IN RABBIT AORTIC SMOOTH-MUSCLE CELLS

      Biochemical journal
    41. SOUTHGATE KM; FISHER M; BANNING AP; THURSTON VJ; BAKER AH; FABUNMI RP; GROVES PH; DAVIES M; NEWBY AC
      UP-REGULATION OF BASEMENT MEMBRANE-DEGRADING METALLOPROTEINASE SECRETION AFTER BALLOON INJURY OF PIG CAROTID ARTERIES

      Circulation research
    42. MCELLIGOTT A; BAKER AH; MCGLYNN H
      MATRIX METALLOPROTEINASE REGULATION IN RENAL-CANCER

      British Journal of Cancer
    43. TAYLOR C; MCGLYNN H; CARTER G; BAKER AH; WARREN N; RIDGE SA; OWEN G; THOMPSON E; THOMPSON PW; JACOBS A; PADUA RA
      RAS AND FMS MUTATIONS FOLLOWING CYTOTOXIC THERAPY FOR CHILDHOOD ACUTELYMPHOBLASTIC-LEUKEMIA

      Leukemia
    44. BAKER AH; BALL S; MCGLYNN H; WHITTAKER JA; BURNETT AK; PADUA RA
      A C-TERMINAL FMS MUTATION IN A PATIENT WITH B-CELL MALIGNANCY

      Leukemia
    45. BAKER AH; CACHIA PG; TENNANT GB; WHITTAKER JA; WHITE D; STANLEY ER; BURNETT AK; PADUA RA
      A NOVEL CSF-1 BINDING-FACTOR IN A PATIENT IN COMPLETE REMISSION FOLLOWING CYTOTOXIC THERAPY FOR LYMPHOMA

      British Journal of Haematology
    46. BAKER AH; MCGLYNN H; CONLON FV; PADUA RA
      FMS PROMOTER STUDIES IN B-LYMPHOCYTES

      Blood
    47. MCGLYNN H; BAKER AH; DIBB NJ; BURNETT AK; PADUA RA
      COLONY-STIMULATING FACTOR-I RECEPTOR (CSF-1R) INTERNALIZATION STUDIESIN HEMATOPOIETIC-CELLS

      Experimental hematology
    48. MCGLYNN H; BAKER AH; RIDGE SA; CACHIA PG; WHITTAKER JA; BURNETT AK; PADUA RA
      FMS MUTATIONS IN PATIENTS IN REMISSION FOLLOWING CYTOTOXIC THERAPY FOR LYMPHOMA AND CHILDHOOD LEUKEMIA

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/04/20 alle ore 08:35:02